MARGARET LELAND: Open Payments
NPI 1922569516 · COLFAX, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$189 in 9 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $22 · 2025 $189
Food & beverage: $189
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $65 |
| Novo Nordisk Inc | 2 | $45 |
| PFIZER INC. | 1 | $26 |
| Neurocrine BioSciences, Inc. | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $15 |
Products named: QULIPTA, NURTEC ODT, Rybelsus, INGREZZA, Ozempic, UBRELVY, TRELEGY ELLIPTA, Auvelity.
Industry payments across WA — which companies pay providers there.
